Grid Therapeutics is an emerging clinical stage biotechnology company located in Durham, North Carolina. We have made a commitment to our patients and families to develop better and safer therapeutic antibodies for cancer.

Based on fundamental principles of anti-tumor immunity, Grid Therapeutics has a unique strategy to rapidly and efficiently develop novel tumor-specific therapeutic antibodies for the treatment of multiple cancer types directly from single human B cells.

Keep yourself updated with the latest news from Grid. Check back regularly for new content posted weekly about cancer treatment and the search for a cure!